ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0047

Administrative Barriers to Enrollment of Ethnic Minorities in Clinical Research of Rheumatic/Immune-Mediated Diseases

Brittany Banbury1, Sharon Dowell1, Gail Kerr2, Mercedes Quinones2, Ginette Okoye1 and Ilona Jileaeva1, 1Howard University Hospital, Washington, DC, 2Washington DC VA Medical Center, Washington, DC

Meeting: ACR Convergence 2020

Keywords: Data Management, Disparities, Education, Health Services Research, Minority Health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Inclusion of ethnic minority subsets in clinical research remains subpar despite mandates for increased participation. Lack of trust, cultural sensitivity and bias, stereotyping, health literacy are all acknowledged barriers that are active areas of rehabilitation 4, 5. Ethnic minority patients are often cared for by ethnic minority physicians, and despite their limited health coverage, target academic institutions to receive care1, 2.Therefore, academic institutions with ethnic minority clienteles and physicians are the prime targets for recruitment of non-Caucasians in clinical trials. However, whether administrative operations at ethnic minority institutions can facilitate this process, and in timely fashion, is unknown. We examined the time intervals for approval of administrative procedures for clinical research at a predominantly ethnic minority academic institution.  

Objective: To assess time intervals for the administrative approval procedures for clinical research at a predominantly ethnic minority institution.

Methods: At a single historically Black academic institution (HBCU), we examined the time points for multiple clinical trials between submission and responses to institutional review board review, and contract negotiations. The agreed contractual numbers for each study and their unit reimbursement were also obtained. Time to approval of each stage was documented, including the final approval in relation to study initiation.

Results: The average time for IRB approval across 8 clinical trials was 3.75 months, ~ 6 weeks longer than other local academic institutions (1.5-3m). The most frequent reason for delay was multiple, repetitive queries, which could have been avoided by systematic review processes. Additionally, contract approval for 4 funded clinical trials was 8.5 months, resulting in the inability to recruit patients before study closure, with potential loss of institutional funds ($10, 226/patient).

Conclusion: At a single HBCU academic site, there was a consistent, prolonged interval for each step of approval of clinical research. Although it is unknown if enrollment would have met targets, these results suggest a significant lost opportunity for inclusion of ethnic minority subsets in clinical trials. Further, the potential loss of revenue to the institution due to these inefficiencies, cannot be ignored. Measures to improve the process must therefore be an integral requirement of the overall process for increased ethnic minority involvement in clinical research.


Disclosure: B. Banbury, None; S. Dowell, Horizon Pharma, 8, Bristol Myers Squbb, 2, Pfizer, 2; G. Kerr, Novartis, 1, BMS, 1, 2, Gilead, 1, Regeneron, 1, Janssen, 1; M. Quinones, Pfizer, 2, Ampel, 2, Biogen, 2, Sanofi Genzyme, 8; G. Okoye, Pfizer, 2, Unilever, 5; I. Jileaeva, None.

To cite this abstract in AMA style:

Banbury B, Dowell S, Kerr G, Quinones M, Okoye G, Jileaeva I. Administrative Barriers to Enrollment of Ethnic Minorities in Clinical Research of Rheumatic/Immune-Mediated Diseases [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/administrative-barriers-to-enrollment-of-ethnic-minorities-in-clinical-research-of-rheumatic-immune-mediated-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/administrative-barriers-to-enrollment-of-ethnic-minorities-in-clinical-research-of-rheumatic-immune-mediated-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology